^
ARID2 H1495fs*8
Kidney Medullary Carcinoma
nivolumab
Sensitive: C4 – Case Studies
SMARCB1 deletion
Kidney Medullary Carcinoma
nivolumab
Sensitive: C4 – Case Studies
NF2 mutation
Kidney Medullary Carcinoma
bevacizumab + erlotinib
Sensitive: C4 – Case Studies